SAN DIEGO, Nov. 28, 2017 /PRNewswire/ -- Shareholder Rights
Law Firm Johnson Fistel, LLP is investigating potential claims
against INC Research Holdings, Inc., Acorda Therapeutics, Inc., and
Shopify Inc. as detailed below:
INC Research Holdings, Inc.
Shareholder rights law firm Johnson Fistel, LLP is investigating
potential violations of the federal securities laws by INC Research
Holdings, Inc. ("INC Research") (NASDAQ: INCR).
On November 9, 2017, INC Research
reported its first financial results after merging with inVentiv
Health. INC Research's combined results were adversely impacted by
merger-related expenses, an impairment charge and increased
amortization expenses. Following the news, INC Research stock fell
significantly.
If you purchased INC Research common stock between May 1, 2017 and November
9, 2017 and are interested in learning more about your legal
rights and remedies, please contact Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If you
email, please include your phone number.
Acorda Therapeutics, Inc.
Shareholder Rights Law Firm
Johnson Fistel, LLP today announced that it is investigating
whether certain officers or directors of Acorda Therapeutics, Inc.
("Acorda") (NASDAQ: ACOR) violated federal or state laws.
A Securities Class Action Complaint was filed on behalf of those
who purchased securities of Acorda between April 18, 2016 through November 14, 2017.
According to the lawsuit, defendants during the Class Period
made materially false and misleading statements and failed to
disclose that: (1) tozadenant entailed significant undisclosed
safety risks; (2) accordingly, Acorda had overstated tozadenant's
approval prospects and commercial viability; (3) for the foregoing
reasons, Acorda had likewise overstated the benefits of the Biotie
Acquisition; and (4) as a result, Acorda's shares traded at
artificially inflated prices during the Class Period. When the true
details entered the market, the lawsuit claims that investors
suffered damages.
If you wish to serve as a lead plaintiff, you must move the
Court no later than January
17, 2018.
If you are a long-term shareholder of Acorda shares and
continuously held shares before April 18,
2016, you may have standing to hold Acorda harmless from the
damage the officers and directors may have caused by making them
personally responsible. You may also be able to assist in reforming
the Company's corporate governance to prevent future
wrongdoing.
If you are an Acorda shareholder and are interested in learning
more about your legal rights and remedies, please contact Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If you email,
please include your phone number.
Shopify Inc.
Johnson
Fistel, LLP is investigating potential violations of the
federal securities laws by Shopify Inc. ("Shopify")
(NYSE: SHOP) and certain of its officers.
On October 4, 2017, Citron Research published a report
describing Shopify as "a completely illegal get-rich quick scheme"
and alleges that Shopify is engaging in business practices that are
prohibited by the Federal Trade Commission. Following this news,
Shopify's stock dropped over 11.00%.
If you have information that could assist in this investigation,
including former employees and others, or if you are a Shopify
shareholder and are interested in learning more about the
investigation or your legal rights and remedies, please contact
Jim Baker
(jimb@johnsonfistel.com) by email or by phone at 619-814-4471.
If you email, please include your phone number.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
http://www.johnsonfistel.com. Attorney advertising. Past results do
not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
View original
content:http://www.prnewswire.com/news-releases/johnson-fistel-announces-investigations-of-inc-research-holdings-inc-acorda-therapeutics-inc-and-shopify-inc-investors-encouraged-to-contact-firm-300562525.html
SOURCE Johnson Fistel, LLP